0.9555
price down icon22.94%   -0.2845
after-market Handel nachbörslich: .99 0.0345 +3.61%
loading

Renovorx Inc Aktie (RNXT) Neueste Nachrichten

pulisher
12:22 PM

RenovoRx’s PanTheR Registry Trial: A Promising Update for Investors - TipRanks

12:22 PM
pulisher
05:32 AM

How to recover losses in RenovoRx Inc. stock2025 Earnings Impact & Weekly High Potential Stock Alerts - Newser

05:32 AM
pulisher
05:04 AM

RenovoRx Revenue Jumps 28 Percent in Q2 - AOL.com

05:04 AM
pulisher
04:57 AM

What makes RenovoRx Inc. stock price move sharplyEarnings Overview Report & Short-Term High Return Ideas - Newser

04:57 AM
pulisher
03:24 AM

RenovoRx Inc (RNXT) Q2 2025 Earnings Call Highlights: Strong Market Demand and Strategic Trials ... - Yahoo Finance

03:24 AM
pulisher
01:01 AM

RenovoRx Reports Commercial Revenue Growth in the Second Quarter 2025 and Announces Positive Independent Data Monitoring Committee Recommendation to Continue Pivotal Phase III TIGeR-PaC Trial Based on Interim Data Review - BioSpace

01:01 AM
pulisher
12:54 PM

RenovoRx Reports Revenue Growth and Trial Progress - TipRanks

12:54 PM
pulisher
12:26 PM

RenovoRx (RNXT): Navigating Short-Term Losses for Long-Term Oncology Breakthroughs - AInvest

12:26 PM
pulisher
Aug 14, 2025

What indicators show strength in RenovoRx Inc.Market Risk Analysis & Real-Time Volume Trigger Notifications - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Earnings call transcript: RenovoRx Q2 2025 reveals revenue challenges By Investing.com - Investing.com Canada

Aug 14, 2025
pulisher
Aug 14, 2025

RenovoRx earnings beat, revenue fell short of estimates By Investing.com - Investing.com Nigeria

Aug 14, 2025
pulisher
Aug 14, 2025

RenovoRx Reports Strong Q2 2025 Revenue Growth - TipRanks

Aug 14, 2025
pulisher
Aug 14, 2025

Earnings call transcript: RenovoRx Q2 2025 reveals revenue challenges - Investing.com

Aug 14, 2025
pulisher
Aug 14, 2025

RenovoRx earnings beat, revenue fell short of estimates - Investing.com

Aug 14, 2025
pulisher
Aug 14, 2025

RenovoRx, Inc. (RNXT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Aug 14, 2025
pulisher
Aug 14, 2025

RenovoRx Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 14, 2025
pulisher
Aug 14, 2025

Using Ichimoku Cloud for RenovoRx Inc. technicalsQuarterly Trade Review & Reliable Breakout Forecasts - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Moving Average Crossover Confirms Uptrend in RenovoRx Inc.2025 Geopolitical Influence & AI Powered Market Entry Ideas - thegnnews.com

Aug 14, 2025
pulisher
Aug 14, 2025

Using data filters to optimize entry into RenovoRx Inc.Options Play & Fast Gain Stock Trading Tips - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Price momentum metrics for RenovoRx Inc. explained2025 Analyst Calls & Consistent Profit Trading Strategies - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Visual trend scoring systems applied to RenovoRx Inc.Portfolio Risk Summary & Safe Entry Trade Signal Reports - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Will RenovoRx Inc. continue its uptrendJuly 2025 Institutional & High Conviction Buy Zone Picks - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Can swing trading help recover from RenovoRx Inc. lossesMarket Movers & AI Enhanced Execution Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Will RenovoRx Inc. continue its uptrend [Market Performance Recap]Community Trade Idea Sharing - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

RenovoRx Inc. Testing Reversal Zone on Weekly ChartLong Hold Safe Return Strategy Reviewed - 선데이타임즈

Aug 13, 2025
pulisher
Aug 13, 2025

Can trapped investors hope for a rebound in RenovoRx Inc.Product Launch & Daily Entry Point Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

What data driven models say about RenovoRx Inc.’s futureFree News Based Entry Opportunity Alerts - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Is RenovoRx Inc. stock bottoming outNear-Term Market Opportunity Forecast Sheet - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

What the charts say about RenovoRx Inc. todayFree Daily Chart Pattern Stock Forecast - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

How RenovoRx Inc. stock performs during market volatilityDaily Market Movers Screener with Filters - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Is RenovoRx Inc. stock heavily shortedPower Growth Investing List - 뉴스임팩트

Aug 12, 2025
pulisher
Aug 12, 2025

Can RenovoRx Inc. outperform in the next rallyTop Earnings Growth Momentum Picks - kangso.co.kr

Aug 12, 2025
pulisher
Aug 11, 2025

RenovoRx Inc. stock momentum explainedMomentum Stocks with Breakout Potential - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

RenovoRx RNXT Q2 2025 Earnings Preview Upside Anticipated Amid Clinical Trial Developments - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

RenovoRx Initiates Multi-Center Registry Study for RenovoCath Device - Medical Product Outsourcing

Aug 11, 2025
pulisher
Aug 11, 2025

RenovoRx, Inc.'s (NASDAQ:RNXT) Shift From Loss To Profit - Yahoo Finance

Aug 11, 2025
pulisher
Aug 11, 2025

Why RenovoRx Inc. stock attracts strong analyst attentionFree Weekly Hot Picks With Buy Confidence - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Volume spikes in RenovoRx Inc. stock – what they meanFree Trade Setups With Clear Risk Limits - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Signal strength of RenovoRx Inc. stock in tech scannersFree Accurate Buy Point for Momentum Stocks - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Is RenovoRx Inc. trending in predictive chart modelsFree Momentum Based Equity Trading Plan - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Is this a good reentry point in RenovoRx Inc.Triple Digit Gain Opportunity Watchlist - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

Will RenovoRx Inc. price bounce be sustainableDaily Pattern Analysis with Return Forecast - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Why did RNXT's EPS remain flat throughout 2023? - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

RenovoRx Inc. Breakout Confirmed by Volume MetricsGrowth Based Investment Plan Guidance Highlighted - beatles.ru

Aug 09, 2025
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
Kapitalisierung:     |  Volumen (24h):